Bryn Mawr Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Bryn Mawr Capital Management's MDT Position: Q2 2026 in Review
Bryn Mawr Capital Management increased its Medtronic (MDT) stake by 1.6% in Q2 2026, buying an estimated $179K and bringing the position to 140,236 shares worth $11M. The position accounts for 0.48% of the portfolio, ranked #54.
Bryn Mawr Capital Management first reported a position in MDT in Q1 2022 and has held it in 18 quarters since. The position peaked at $13.4M in Q3 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Bryn Mawr Capital Management held 140,236 shares of Medtronic worth $11M as of Q2 2026.
- Bryn Mawr Capital Management bought 2,217 Medtronic shares in Q2 2026, an estimated $179K.
- Medtronic made up 0.48% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #54 holding.
- Bryn Mawr Capital Management first reported a position in Medtronic in Q1 2022 and has held it in 18 quarters since.
- Bryn Mawr Capital Management's Medtronic position peaked at $13.4M in Q3 2025.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.